Skip NavigationSkip to Content

Integrase of Mason-Pfizer monkey virus

  1. Author:
    Snasel, J.
    Krejcik, Z.
    Jencova, V.
    Rosenberg, I.
    Ruml, T.
    Alexandratos, J.
    Gustchina, A.
    Pichova, I.
  2. Author Address

    Acad Sci Czech Republ, Inst Organ Chem & Biochem, CR-16610 Prague 6, Czech Republic. Acad Sci Czech Republ, Inst Mol Genet, CR-16610 Prague, Czech Republic. Acad Sci Czech Republ, Ctr Integrated Gen, CR-16610 Prague 6, Czech Republic. NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA Pichova, I, Acad Sci Czech Republ, Inst Organ Chem & Biochem, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic
    1. Year: 2005
    2. Date: JAN
  1. Journal: Febs Journal
    1. 272
    2. 1
    3. Pages: 203-216
  2. Type of Article: Article
  1. Abstract:

    The gene encoding an integrase of Mason-Pfizer monkey virus (M-PMV) is located at the 3'-end of the pol open reading frame. The M-PMV integrase has not been previously isolated and characterized. We have now cloned, expressed, isolated, and characterized M-PMV integrase and compared its activities and primary structure with those of HIV-1 and other retroviral integrases. M-PMV integrase prefers untranslated 3'-region-derived long-terminal repeat sequences in both the 3'-processing and the strand transfer activity assays. While the 3'-processing reaction catalyzed by M-PMV integrase was significantly increased in the presence of Mn2+ and Co2+ and was readily detectable in the presence of Mg2+ and Ni2+ cations, the strand transfer activity was strictly dependent only on Mn2+. M-PMV integrase displays more relaxed substrate specificity than HIV-1 integrase, catalyzing the cleavage and the strand transfer of M-PMV and HIV-1 long-terminal repeat-derived substrates with similar efficiency. The structure-based sequence alignment of M-PMV, HIV-1, SIV, and ASV integrases predicted critical amino acids and motifs of M-PMV integrase for metal binding, interaction with nucleic acids, dimerization, protein structure maintenance and function, as well as for binding of human immunodeficiency virus type 1 and Rous avian sarcoma virus integrase inhibitors 5-CI-TEP, DHPTPB and Y-3

    See More

External Sources

  1. DOI: 10.1111/j.1432-1033.2004.04386.x
  2. WOS: 000227358000018

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel